Literature DB >> 15802133

A fluorogenic substrate for the continuous assaying of aryl sulfatases.

Vanessa Ahmed1, Mehdi Ispahany, Scott Ruttgaizer, Guy Guillemette, Scott D Taylor.   

Abstract

The most common fluorogenic substrate for assaying aryl sulfatases (ARSs) is 4-methylumbelliferyl sulfate (MUS). However, ARSs operate optimally at pH values that are less than the pK(a) (7.8) of the reaction product of MUS, 4-methylumbelliferone (4-MU). Thus, a major disadvantage of this assay is that it is usually run in a discontinuous mode due to the need for basification of the reaction mixture to achieve complete ionization of the phenolic products and maximum fluorescence. To circumvent this problem, 6,8-difluoro-4-methylumbelliferyl sulfate (DiFMUS) was prepared and examined as a substrate for ARSs. The product of the reaction is 6,8-difluoro-4-methylumbelliferone, a known coumarin with fluorescent properties equal to those of 4-MU, and has a pK(a) of 4.9. This allowed for the continuous assaying of human placental ARSs A, B, and C, which operate optimally between pH 5.0 and pH 7.0. Furthermore, DiFMUS exhibited a lower K(m) (up to 20-fold) for the ARSs than did MUS; for ARSA and ARSB, it exhibited a greater V(max) than did MUS. This substrate should have considerable utility for the continuous assay of ARS activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802133     DOI: 10.1016/j.ab.2005.02.007

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  An expanded set of fluorogenic sulfatase activity probes.

Authors:  Elizabeth L Smith; Carolyn R Bertozzi; Kimberly E Beatty
Journal:  Chembiochem       Date:  2014-04-24       Impact factor: 3.164

2.  Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains.

Authors:  Kimberly E Beatty; Monique Williams; Brian L Carlson; Benjamin M Swarts; Robin M Warren; Paul D van Helden; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.